Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19534Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pavlidis, N. | en |
| dc.contributor.author | Briassoulis, E. | en |
| dc.contributor.author | Bai, M. | en |
| dc.contributor.author | Fountzilas, G. | en |
| dc.contributor.author | Agnantis, N. | en |
| dc.date.accessioned | 2015-11-24T19:00:27Z | - |
| dc.date.available | 2015-11-24T19:00:27Z | - |
| dc.identifier.issn | 0250-7005 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19534 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adenocarcinoma/genetics/metabolism/secondary | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Carcinoma/genetics/metabolism/*secondary | en |
| dc.subject | Carcinoma, Squamous Cell/genetics/pathology/secondary | en |
| dc.subject | Female | en |
| dc.subject | *Gene Expression Regulation, Neoplastic | en |
| dc.subject | Humans | en |
| dc.subject | Immunoenzyme Techniques | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Neoplasm Proteins/*biosynthesis/genetics | en |
| dc.subject | *Neoplasms, Unknown Primary | en |
| dc.subject | Proto-Oncogene Proteins c-myc/*biosynthesis/genetics | en |
| dc.subject | Proto-Oncogene Proteins p21(ras)/*biosynthesis/genetics | en |
| dc.subject | Receptor, erbB-2/*biosynthesis/genetics | en |
| dc.title | Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/8669824 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1995 | - |
| heal.abstract | The role of oncogenes in carcinoma of unknown primary site (CUP) has not yet been elucidated. In the present study the expression of the c-myc p62, ras p21 and c-erB-2 p185 oncoproteins were studied by a 3-step immunoperoxidase technique in 26 cases of CUP. Positive immunoreactivity was observed in 96% of the cases for c-myc, 92% for ras and in 65% for c-erb-2, with at least half of tumor cells labelled in 85%, 92% and 58% respectively. The degree of staining intensity was considered moderate or strong in more than half of the cases for all oncogene products. In conclusion, our results showed that patients with CUP have an extremely high overexpression of all three oncogenes studied. Nevertheless, the biological role of these overexpressed oncoproteins, their relationship with different histological or clinical parameters and their diagnostic or prognostic value need further evaluation. | en |
| heal.journalName | Anticancer Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
